These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 31997405)

  • 1. Targeting microglia L-type voltage-dependent calcium channels for the treatment of central nervous system disorders.
    Hopp SC
    J Neurosci Res; 2021 Jan; 99(1):141-162. PubMed ID: 31997405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-type voltage-dependent calcium channels as therapeutic targets for neurodegenerative diseases.
    Yagami T; Kohma H; Yamamoto Y
    Curr Med Chem; 2012; 19(28):4816-27. PubMed ID: 22834820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium dysregulation via L-type voltage-dependent calcium channels and ryanodine receptors underlies memory deficits and synaptic dysfunction during chronic neuroinflammation.
    Hopp SC; D'Angelo HM; Royer SE; Kaercher RM; Crockett AM; Adzovic L; Wenk GL
    J Neuroinflammation; 2015 Mar; 12():56. PubMed ID: 25888781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium ion influx in microglial cells: physiological and therapeutic significance.
    Sharma P; Ping L
    J Neurosci Res; 2014 Apr; 92(4):409-23. PubMed ID: 24464907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-type calcium channels as drug targets in CNS disorders.
    Ortner NJ; Striessnig J
    Channels (Austin); 2016; 10(1):7-13. PubMed ID: 26039257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor-1α regulates the expression of L-type voltage-dependent Ca(2+) channels in PC12 cells under hypoxia.
    Li R; Wang Y; Yang Z; He Y; Zhao T; Fan M; Wang X; Zhu L; Wang X
    Cell Stress Chaperones; 2015 May; 20(3):507-16. PubMed ID: 25648081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential rescue of spatial memory deficits in aged rats by L-type voltage-dependent calcium channel and ryanodine receptor antagonism.
    Hopp SC; D'Angelo HM; Royer SE; Kaercher RM; Adzovic L; Wenk GL
    Neuroscience; 2014 Nov; 280():10-8. PubMed ID: 25224829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of microglial Cav1.2 Ca
    Wang X; Saegusa H; Huntula S; Tanabe T
    Sci Rep; 2019 Jun; 9(1):9138. PubMed ID: 31235768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ion channels on microglia: therapeutic targets for neuroprotection.
    Skaper SD
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca
    Pinggera A; Striessnig J
    J Physiol; 2016 Oct; 594(20):5839-5849. PubMed ID: 26842699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7.
    Torres-Rico M; García-Calvo V; Gironda-Martínez A; Pascual-Guerra J; García AG; Maneu V
    Cell Calcium; 2024 Nov; 123():102928. PubMed ID: 39003871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Cyclin-dependent kinase 5 on voltage-dependent calcium channels in PC12 cells varies according to channel type and cell differentiation state.
    Furusawa K; Asada A; Saito T; Hisanaga S
    J Neurochem; 2014 Aug; 130(4):498-506. PubMed ID: 24766160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential neuroprotective and anti-inflammatory effects of L-type voltage dependent calcium channel and ryanodine receptor antagonists in the substantia nigra and locus coeruleus.
    Hopp SC; Royer SE; D'Angelo HM; Kaercher RM; Fisher DA; Wenk GL
    J Neuroimmune Pharmacol; 2015 Mar; 10(1):35-44. PubMed ID: 25318607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower Affinity of Isradipine for L-Type Ca
    Ortner NJ; Bock G; Dougalis A; Kharitonova M; Duda J; Hess S; Tuluc P; Pomberger T; Stefanova N; Pitterl F; Ciossek T; Oberacher H; Draheim HJ; Kloppenburg P; Liss B; Striessnig J
    J Neurosci; 2017 Jul; 37(28):6761-6777. PubMed ID: 28592699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voltage-Dependent Calcium Channels, Calcium Binding Proteins, and Their Interaction in the Pathological Process of Epilepsy.
    Xu JH; Tang FR
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The L-type voltage-gated calcium channel modulates microglial pro-inflammatory activity.
    Espinosa-Parrilla JF; Martínez-Moreno M; Gasull X; Mahy N; Rodríguez MJ
    Mol Cell Neurosci; 2015 Jan; 64():104-15. PubMed ID: 25497271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.
    Zamponi GW; Striessnig J; Koschak A; Dolphin AC
    Pharmacol Rev; 2015 Oct; 67(4):821-70. PubMed ID: 26362469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of microglial Cav2.2 N-type voltage-dependent Ca
    Saegusa H; Li X; Wang X; Kayakiri M; Tanabe T
    FEBS Lett; 2020 Sep; 594(17):2914-2922. PubMed ID: 32484574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of L-Type Ca
    Sun Y; Zhang H; Selvaraj S; Sukumaran P; Lei S; Birnbaumer L; Singh BB
    J Neurosci; 2017 Mar; 37(12):3364-3377. PubMed ID: 28258168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.